23 Nov 2004
CNSSeminar Dr Tachi Yamada, Chairman Research & development presented on GSK's Central Nervous System pipeline and portfolio. He was joined by senior representatives from the R&D team who presented to an audience of analysts and investors.

09 Nov 2004
Credit Suisse First Boston 5th Annual European Large Cap Pharmaceutical Conference
Andrew Witty, President Pharmaceuticals Europe, gave a presentation at the CSFB Pharmaceutical Conference on 9 November in London. The presentation was attended by approx 100 institutional investors and portfolio managers. Andrew presented an overview of GSK including a specific focus on
Europe.

28 Oct 2004
GlaxoSmithKline 2004 Q3 Results

21 Sep 2004
Merrill Lynch Global Drug, Biotech and Medical Devices Conference
Al Gianchetti, VP Commercial Strategy, Cardiovascular and Metabolic Therapy Area, Commercial Development US, gave a presentation at the Merrill Lynch Conference on 21 September in London. The presentation was attended by over 100 institutional investors and portfolio managers. Al presented on the Cardiovascular and Metabolic product portfolio and pipeline, reaffirming belief in the company’s ability to deliver growth from R&D going forward.

14 Sep 2004
Bear Stearns 17th Annual Healthcare Conference
David Stout, President, Pharmaceutical Operations, gave a presentation at the Bear Stearns 17th Annual Healthcare Conference on September 14 in New York. The presentation was attended by over 100 institutional investors and portfolio managers. David provided highlights from the 2nd quarter and discussed some of GSK's key growth products.

27 Jul 2004
GlaxoSmithKline2004 Q2 Results

20 Jul 2004
Medicare Drug Benefit Seminar

28 Jun 2004
Lehman Brothers Investor Teleconference on HIV
Peter Hare, VP HIV Business Unit, gave a presentation to a group of Investors over a teleconference updating them on our HIV franchise.

24 Jun 2004
Morgan Stanley Investor Roadshow
Darrell Baker, SVP Respiratory MDC, gave a presentation to a group of Investors at GSK House updating them on our Respiratory franchise.

09 Jun 2004
Goldman Sachs 25th Annual Global Healthcare Conference
David Stout, President, Pharmaceuticals, gave a presentation at the Goldman Sachs Twenty-Fifth Annual Global Healthcare Conference on June 9 in California. The conference featured presentations by more than 120 healthcare companies from the United States, Europe and Japan. David provided an overview of GSK's progress, focusing on 1Q financial results and key growth products.

02 Jun 2004
Sanford C. Bernstein 20th Annual Strategic Decisions Conference
JP Garnier, Chief Executive Officer, gave a presentation at the Sanford C. Bernstein 20th Annual Strategic Decisions Conference on June 2 in New York. More than 200 institutional portfolio managers and analysts attended the meeting. JP provided highlights from the first quarter and discussed some of GSK's key growth products and some of the company's late-stage R&D projects.

Deutsche Bank Securities 29th Annual Health Care Conference
David Stout, President, Pharmaceuticals, gave a presentation at the Deutsche Bank Securities 29th Annual Health Care Conference on May 4, 2004 in Baltimore, Maryland. Approximately 150 public and private companies gave investors updates on their businesses. David provided highlights from GSK's first quarter results and discussed some of GSK's key growth products.

29 Apr 2004
GlaxoSmithKline 2004 Q1 Results

09 Mar 2004
Cowen Health Care Conference
Tachi Yamada, Chairman, Research & development, gave a presentation at the SG Cowen Health Care Conference on March 9, 2004 in Boston. The presentation was attended by over 100 institutional investors and portfolio managers. Tachi presented an overview of GSK's new R&D structure and highlights of the company's maturing pipeline.

12 Feb 2004
GlaxoSmithKline 2003 Annual Results